When the Francis Crick Institute opens in London this year, it will be Europe’s largest biomedical research centre. Can director Paul Nurse make this gamble pay off for UK science?

The US government is considering policy changes that could dramatically affect how researchers handle equipment and information that have national-security implications. Scientists would need to reconsider what they can discuss with graduate students from other countries, or when traveling abroad on work trips.

Thierry Mandon replaces Geneviève Fioraso, who stepped down in March for health reasons, leaving France without anyone heading the research brief for three months.

Proposed controls on foreign operations in China are a threat to scientific collaboration.

Researchers hope that a more pluralistic parliament will put an end to interference and slipping standards.

Study calculates cost of flawed biomedical research in the US.

Initiative trying to validate 50 cancer papers finds difficulty in accessing original study data.

Republicans in the House of Representatives seek to reshape research agenda.

Just a fraction of universities in the United Kingdom have made public the extent of their investigations into research misconduct, a survey has found - even though all have been told that they should do so.

Movement to publicly record peer-reviewing activity gains momentum.

Jo Johnson is smart and well-connected, but will not attend highest-level policy meetings.

Computer scientists are trying to shore up broken links in the scholarly literature.

An ambitious [11]effort to replicate 100 research findings in psychology ended last week - and the data look worrying.

You're in your 60s. Should you stay in the lab, or make way for the next generation?

The fall out from the STAP case is still being felt across Japan.

'Premature' rules for preclinical research need more flexibility and greater community involvement, say scientific society leaders.

Germany's ruling political parties have agreed to plough €5 billion (US$5.4 billion) more into science from 2018 to 2028.

Rumours of germline modification prove true — and look set to reignite an ethical debate.

The $3-million state initiative will coordinate with a national effort to promote individualized patient treatment.

Nature Biotechnology asks peer reviewers to check accessibility of code used in computational studies.

Nature readers favour creating more secure jobs to fix science’s broken postdoctoral system.

There is a growing number of postdocs and few places in academia for them to go. But change could be on the way.